Gillings research on broad-spectrum antiviral could aid public health response to coronavirus outbreaks
January 10, 2020 New research from scientists at the Gillings School reveals that, in mice, remdesivir is more therapeutically effective against the Middle East respiratory coronavirus (MERS-CoV) than comparative antiviral treatments. This broad-spectrum antiviral drug could help public health workers respond more rapidly to coronavirus outbreaks.